• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THERAKOS CELLEX PHOTOPHERESIS SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THERAKOS CELLEX PHOTOPHERESIS SYSTEM Back to Search Results
Model Number NOT APPLICABLE
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Anemia (1706)
Event Date 06/15/2018
Event Type  Injury  
Manufacturer Narrative
The system was used for treatment.This case is reportable as a mdr due to the medical intervention of the ferric carboxymaltose that was provided to the patient.Since this event is associated with the treatment, this mdr will be against the instrument.From the instrument perspective, there was no known instrument malfunction and no instrument issue was alleged by the customer.No service was requested by the customer for this adverse event.No product was returned therefore, a device service history review was performed.The instrument has been located at the customer's site since 22-may-2017.As part of the review, it was determined that the instrument's last service was on 21-may-2018.During this service the system checkout procedure was successfully completed indicating that the instrument had passed all tests, met all specifications, and was operational.Trends were reviewed for complaint category, anemia.No trends were detected for this complaint category.The assessment is based on information available at the time of the investigation.Complaints are monitored through tracking and trending.If a trend is detected, further investigation will be conducted.Adverse event terms: anemia.(b)(4).
 
Event Description
The customer called to report that a patient developed anemia while undergoing extracorporeal photopheresis (ecp) treatment procedures.The customer stated that the patient started their ecp treatment procedures on (b)(6) 2018.The customer reported that the patient received two ecp treatment procedures every week.The customer stated that the patient was diagnosed with anemia on (b)(6) 2018.The customer reported that after the patient's anemia diagnosis, the patient's ecp treatment frequency was changed from twice weekly to twice every other week.The customer stated that the patient also received two doses of 750mg ferric carboxymaltose, which helped the patient.The customer reported that the patient only received one treatment with their new treatment frequency of twice every other week; so it was difficult to say whether this new treatment frequency helped the patient.The customer stated that the patient's ecp treatments were stopped due to the patient's severe anemia and also due to the fact that the patient's skin improvements had reached a plateau.The customer reported that the patient's last ecp treatment procedure was on (b)(6) 2018.The customer stated that both the patient's iron and hemoglobin levels are now within normal limits.The customer reported that the patient was in stable condition.The customer stated that she believed that the patient's ecp treatments and its twice weekly regimen contributed to the patient's anemia.No product was returned for investigation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CELLEX PHOTOPHERESIS SYSTEM
Type of Device
CELLEX PHOTOPHERESIS SYSTEM
Manufacturer (Section D)
THERAKOS
bedminster NJ
Manufacturer (Section G)
MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
college business & tech park
cruiserath road
blanchardstown, dublin D15 T X2V
EI   D15 TX2V
Manufacturer Contact
megan vernak
1425 us route 206
bedminster, NJ 07921
MDR Report Key7896608
MDR Text Key120969348
Report Number2523595-2018-00148
Device Sequence Number1
Product Code LNR
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P860003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Nurse
Type of Report Initial
Report Date 09/20/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/20/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberNOT APPLICABLE
Device Catalogue NumberCELLEX
Device Lot NumberNOT APPLICABLE
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/23/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/05/2014
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age56 YR
-
-